project id: TCGA-ESCA; case submitter id: TCGA-Q9-A6FW; source center: 23; state: released; a260 a280 ratio: 1.91; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.51; rna integrity number: 7.2; age at index: 61; days to birth: -22586; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1952; age at diagnosis: 22586; ajcc pathologic m: M0; ajcc pathologic n: N2; ajcc pathologic stage: Stage IIIB; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 238.0; icd 10 code: C15.5; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lower third of esophagus; synchronous malignancy: No; tissue or organ of origin: Lower third of esophagus; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: No; cigarettes per day: 4.109589041095891; pack years smoked: 75.0; is ffpe: false; composition: Not Reported; days to collection: 62; days to sample procurement: 0; initial weight: 210.0; portion submitter id: TCGA-Q9-A6FW-01A-31; percent lymphocyte infiltration: 10.0; percent monocyte infiltration: 1.0; percent necrosis: 0.0; percent neutrophil infiltration: 2.0; percent normal cells: 3.0; percent stromal cells: 0.0; percent tumor cells: 97.0; percent tumor nuclei: 60.0;